Table 2.

Data of the studied patients.

Patient	Kidney Disease	Age	Gender	BMI	Time on HD (months)	Dialyzer Type and Membrane Area	Dialysis Access	Procedure Type (HD/HDF)
1	Polycystic kidney disease	83	M	23.5	109	FX80-1.8 m2	a/v fistula	HD and HDF
2	Atherosclerosis	57	M	22.5	32	FX80-1.8 m2	a/v fistula	HD and HDF
3	Diabetic nephropathy	85	M	18.7	36	FX80-1.8 m2	a/v fistula	HD and HDF
4	Hypertensive renal disease	81	F	34.6	12	FX80-1.8 m2	graft	HD and HDF
5	Diabetic nephropathy	84	M	24.4	29	FX80-1.8 m2	a/v fistula	HD and HDF
6	Polycystic kidney disease	49	M	16.7	45	FX80-1.8 m2	a/v fistula	HD and HDF
7	Diabetic nephropathy	76	M	29.0	32	FX80-1.8 m2	a/v fistula	HD and HDF
8	Atherosclerosis	73	M	33.2	24	FX80-1.8 m2	a/v fistula	HD and HDF
9	Glomerulo-nephritis	69	F	27.1	47	FX10-1.8 m2	a/v fistula	HD
10	Tubulointerstitial nephritis	62	F	20.3	7	FX10-1.8 m2	a/v fistula	HD
11	Diabetic nephropathy	60	F	26.4	24	FX80-1.8 m2	graft	HDF
12	Polycystic kidney disease	68	M	27.8	96	FX80-1.8 m2	graft	HDF
13	Polycystic kidney disease	43	M	23.9	16	FX80-1.8 m2	graft	HDF
14	Tubulointerstitial nephritis	60	M	27.1	26	FX80-1.8 m2	a/v fistula	HDF
15	Hypertensive renal disease	48	M	27.8	8	FX10-1.8 m2	a/v fistula	HD
16	Hypertensive renal disease	59	M	26.9	28	FX80-1.8 m2	a/v fistula	HDF
17	Myeloma	56	F	30.5	28	FX80-1.8 m2	graft	HDF
18	Myeloma	58	M	25.6	29	FX80-1.8 m2	a/v fistula	HDF
19	Diabetic nephropathy	74	F	27.0	37	FX10-1.8 m2	a/v fistula	HD
20	Polycystic kidney disease	46	M	22.6	42	FX80-1.8 m2	graft	HDF
21	Myeloma	58	F	30.5	53	FX100-1.8 m2	graft	HDF
22	Tubulointerstitial nephritis	43	F	19.0	23	FX80-1.8 m2	a/v fistula	HDF
23	Hypertensive renal disease	73	M	27.1	44	FX80-1.8 m2	permanent dialysis catheter	HDF
24	Tubulointerstitial nephritis	56	M	23.9	52	FX80-1.8 m2	a/v fistula	HDF
25	Diabetic nephropathy	58	M	37.6	36	FX100-1.8 m2	a/v fistula	HDF
26	Hypertensive renal disease	80	M	20.3	81	FX10-1.8 m2	a/v fistula	HD
27	Myeloma	60	M	25.3	55	FX100-1.8 m2	a/v fistula	HDF
28	Tubulointerstitial nephritis	64	F	23.0	28	FX80-1.8 m2	a/v fistula	HD